酒井　治助手

博士（獣医学）

https://researchmap.jp/o_sakai_13

小動物の腫瘍性疾患に対する病態解析、新規治療法の探索

1. Sakai O, Yamamoto H, Igase M, Mizuno T. Optimization of Culture Conditions for the Generation of Canine CD20-CAR-T Cells for Adoptive Immunotherapy. In Vivo. 2022 Mar-Apr;36(2):764-772.
2. Sakai O, Ogino S, Tsukui T, Igase M, Mizuno T. Development of a monoclonal antibody for the detection of anti-canine CD20 chimeric antigen receptor expression on canine CD20 chimeric antigen receptor-transduced T cells. J Vet Med Sci. 2021 Oct 2;83(10):1495-1499.
3. Sakai O, Igase M, Mizuno T. Optimization of canine CD20 chimeric antigen receptor T cell manufacturing and in vitro cytotoxic activity against B-cell lymphoma. Vet Comp Oncol. 2020 Dec;18(4):739-752.
4. Sakai O, Ii T, Uchida K, Igase M, Mizuno T. Establishment and Characterization of Monoclonal Antibody Against Canine CD8 Alpha. Monoclon Antib Immunodiagn Immunother. 2020 Aug;39(4):129-134.
5. Sakai O, Sakurai M, Sakai H, Kubo M, Hiraoka H, Baba K, Okuda M, Mizuno T. Molecular cloning of canine Wilms' tumor 1 for immunohistochemical analysis in canine tissues. J Vet Med Sci. 2017 Jul 28;79(7):1272-1277.